KROS
Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Keros Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 367000, a 99.83% decrease year-over-year.
- Keros Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 244.0 M, a 47195.16% increase year-over-year.
- Keros Therapeutics Inc. annual revenue for 2025 was 244.1 M, a 6774.96% increase from 2024.
- Keros Therapeutics Inc. annual revenue for 2024 was 3.5 M, a 2250.99% increase from 2023.
- Keros Therapeutics Inc. annual revenue for 2023 was 151000.
- Keros Therapeutics Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Keros Therapeutics Inc. Earnings — FAQ
Keros Therapeutics Inc. (KROS) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's earnings history?
The chart and table above show Keros Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.